NovaBridge Biosciences

Stock Chart, Company Information, and Scan Results

$3.50(as of Mar 6, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

NovaBridge Biosciences Company Information, Fundamentals, and Technical Indicators

Stock Price$3.50
Ticker SymbolNBP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees32
CountyUSA
Market Cap$358.6M
EBIDTA-34.7M
10-Day Moving Average3.30
P/E Ratio-5.53
20-Day Moving Average3.33
Forward P/E Ratio0.00
50-Day Moving Average3.67
Earnings per Share-0.32
200-Day Moving Average3.55
Profit Margin-Infinity%
RSI56.39
Shares Outstanding115.3M
ATR0.28
52-Week High6.79
Volume2,257,745
52-Week Low0.60
Most Recent Support Level3.06
Book Value1,843.3M
Most Recent Resistance Level3.48
P/B Ratio0.20
Upper Keltner3.96
P/S RatioInfinity
Lower Keltner2.70
Debt-to-Equity Ratio3.96
Next Earnings DateUnknown
Cash Surplus1,509.1M
Next Ex-Dividend DateUnknown

NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.

NovaBridge Biosciences In Our Stock Scanner

As of Mar 06, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.